JAMIE HEATHERLY: Open Payments
NPI 1265127989 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,929 in 155 payments from 18 companies in 2025. Trend: 2023 $1,631 · 2024 $2,766 · 2025 $2,929
Food & beverage: $2,830Education: $99
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 43 | $611 |
| ABBVIE INC. | 25 | $431 |
| Novartis Pharmaceuticals Corporation | 19 | $369 |
| UCB, Inc. | 15 | $319 |
| AstraZeneca Pharmaceuticals LP | 11 | $219 |
| E.R. Squibb & Sons, L.L.C. | 10 | $212 |
| Janssen Biotech, Inc. | 5 | $178 |
| GENZYME CORPORATION | 6 | $135 |
| GlaxoSmithKline, LLC. | 5 | $101 |
| Mallinckrodt Hospital Products Inc. | 2 | $61 |
Products named: RINVOQ, COSENTYX, Bimzelx, SAPHNELO, ORENCIA, KRYSTEXXA, TAVNEOS, TREMFYA.
Industry payments across TN — which companies pay providers there.
